Comparison of 18F-DPA714 PET/MRI and 18F-FDG PET/CT in patients with autoimmune encephalitis: a cross-sectional study
- 3 May 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (11) , 4292-4307
Abstract
Background and aim The positive detection rate of MRI in autoimmune encephalitis (AIE) patients is low, often failing to make a rapid and accurate localization diagnosis. Both 18F-DPA714 and 18F-FDG PET imaging techniques have shown their advantages in the diagnosis of AIE. Therefore, the aim of this study was to conduct a head-to-head comparison of the diagnostic value between 18F-DPA714 and 18F-FDG PET in patients with AIE. Methods This cross-sectional study included 23 antibody-positive and 2 possible antibody-negative AIE patients, along with 10 healthy controls. All patients underwent sequential 18F-DPA714 PET/MRI and 18F-FDG PET/CT examinations within one week. A follow-up of 6 to 12 months after the baseline examinations was performed to assess the change of patients' clinical symptoms. Positive findings for 18F-DPA714 PET were defined as Z-score above 2.0 in the corresponding brain regions of healthy controls. Positive results for 18F-FDG PET were indicated by the Z-score above 2.0 or below -2.0 obtained after comparison with the normal population database. Results Both 18F-FDG PET and 18F-DPA714 PET showed higher positivity rates than MRI (81% vs 44%, P = 0.006 and 76% vs 44%, P = 0.008, respectively). A statistically significant association was found between the uptake intensity and extent of 18F-DPA714 but not 18F-FDG with the mRS scores and the CASE scores. Patients with epilepsy showed a significantly higher uptake in the whole-cortex of both 18F-DPA714 (P = 0.0014) and 18F-FDG (P = 0.0051) and in the temporal lobe of 18F-FDG (P = 0.0216) compared to those patients without. Higher 18F-DPA714 SUVR (P < 0.001) and lower 18F-FDG SUVR (P < 0.001) in the whole-cortex of patients with long-term cognitive impairment than those patients without were observed. Conclusion 18F-DPA714 PET showed its better correlation with disease severity of AIE than 18F-FDG PET, serving as a supplementary tool to 18F-FDG PET and MRI.Keywords
Funding Information
- Shanghai Municipal Key Clinical Specialty (shslczdzk03403)
- Shanghai Outstanding Young Scholars Project, National Natural Sciences Foundation of China (82271383)
- open fund from shanxi medical university-collaborative innovation center for molecular imaging of precision medicine
- Natural Science Foundation of Shanghai Municipality (23ZR1440600)
This publication has 43 references indexed in Scilit:
- Cortical Hypometabolism Demonstrated by PET in Relapsing NMDA Receptor EncephalitisPediatric Neurology, 2010
- RESPONSE OF ANTI-NMDA RECEPTOR ENCEPHALITIS WITHOUT TUMOR TO IMMUNOTHERAPY INCLUDING RITUXIMABNeurology, 2008
- Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous casesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's diseaseNature Clinical Practice Neurology, 2006
- Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnnals of Neurology, 2005
- Serial 18F-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Magnetic Resonance Imaging of Paraneoplastic Limbic EncephalitisArchives of Neurology, 2004
- Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patientsBrain, 2000
- Limbic encephalitis: comparison of FDG PET and MR imaging findings.American Journal of Roentgenology, 1998